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Summery 
Ebola virus disease (formerly Ebola hemorrhagic fever) is an acute viral syndrome that presents with fever and an 
ensuing bleeding diathesis that is marked by high mortality in human and nonhuman primates. The disease is 
caused by genus Ebola virus. Ebola virus consists five species namely Zaire ebolavirus, Sudan ebolavirus, Taï 
Forest ebolavirus (formerly Cote d’Ivoire ebolavirus), Reston ebolavirus and Bundibugyo ebolavirus. Among 
them the Bundibugyo ebolavirus, Zaire ebolavirus, and Sudan ebolavirus have been associated with large 
outbreaks in Africa. Fruit bats are considered to be the only natural host of the Ebola virus. Nonhuman primates 
are severely affected by filoviruses. EBOV is thought to enter the human population through exposure to the bodily 
fluids of an infected fruit bat or mammal, especially non-human primates. In general there is no or little evidence 
that domestic animals play an active epidemiological role in the transmission of the disease to humans. Dogs 
appear to be the first animal species shown to be naturally and asymptomatically infected by Ebola virus. The 
diagnosis of EVD is confirmed by isolating the virus, detecting its RNA or proteins by PCR, or detecting antibodies 
against the virus by ELISA. To control EBV disease, good food preparation practices, animal testing for Ebola 
virus, culling of infected animals, with close supervision of burial or incineration of carcasses, may be necessary 
to reduce the risk of animal-to-human transmission. Disease reporting, routine cleaning and disinfection and 
restricting or banning the movement of animals from infected farms to other areas can reduce the spread of the 
disease.  
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1. Introduction 
Ebola virus disease formerly known as Ebola hemorrhagic fever (EHF) is an acute viral syndrome that presents 
with fever and an ensuing bleeding diathesis that is marked by high mortality in human and nonhuman primates. 
The natural reservoir of the virus is unknown. As a result, little is understood about how Ebola virus is transmitted 
or how it replicates in its host. Although the primary source of infection is unknown, the epidemiologic mode of 
transmission is well defined (Casillas et al., 2003). 
Ebola virus disease is one example of emerging infectious diseases which was first discovered in 1976. 
It is a serious and often fatal illness that has been in the news in recent weeks. Recently, there have been largest 
Ebola outbreaks of Ebola virus disease in West Africa. The World Health Organization (WHO) declared it an 
outbreak in March 2014 and on August 8, 2014 a public health emergency of international concern. Based on the 
number of deaths and total number of cases reported to the WHO as of August 11, 2014, the current outbreak has 
an overall mortality rate of 55%. According to the report, number of Ebola-linked cases passes 10,000, and more 
than5, 000 Dead (Semalulu et al., 2014). 
Ebola hemorrhagic fever outbreaks occurred in villages where people keep domestic animals, including 
dogs. Dogs eat small dead animals found near the villages and also internal organs of wild animals hunted and 
slaughtered by villagers. Although canine infection by Ebola virus has never been documented, studies on dogs in 
West Africa have shown that dogs develop antibodies when exposed to Ebola, suggesting that they may develop 
mild infections without becoming sick. However, very little is known about how other domestic animals respond 
to Ebola virus (Loïs et al., 2005). This short review offers the first evidence that dogs might be asymptomatically 
infected by Ebola virus. This finding has potential implications for preventing and controlling human outbreaks 
(Goldsmith and Zaki, 2010). 
Preventing the occurrence of such diseases requires higher levels of biosecurity, and thus, appropriate 
training in medical and veterinary schools and universities, but also general information for all people and 
precautions to minimize the risk of contracting such zoonotic diseases (Goldsmith and Zaki, 2010). 
The objectives of this short review are:- 
 To assess the general knowledge about Ebola virus disease, regarding the possible host which is 
susceptible for the virus, the possible means of transmission from animal to human, ways to reduce 
transmissions and the prevalence in domestic and wild animals.  
 To discuss with societies, particularly those professionals frequently exposed to animals, to be aware of 
EVD, and to take precautions to minimize the risk of contracting such zoonotic disease as it’s very serious 
and chance recovery is very low. 
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2. Ebola Virus Disease 
Ebola hemorrhagic fever (EHF) is an acute viral syndrome that presents with fever and an ensuing bleeding 
diathesis that is marked by high mortality in human and nonhuman primates. Fatality rates are between 50% and 
100%. Due to its lethal nature, this filovirus is classified as a biological class 4 pathogen. The natural reservoir of 
the virus is unknown. As a result, little is understood about how Ebola virus is transmitted or how it replicates in 
its host. Although the primary source of infection is unknown, the epidemiologic mode of transmission is well 
defined (Casillas et al., 2003). 
 
2.1. Historical Back Ground of Ebola Virus Disease 
In 1976, Ebola (named after the Ebola River in Zaire) first emerged in Sudan and Zaire. The first outbreak of Ebola 
(Ebola-Sudan) infected over 284 people, with a mortality rate of 53%. A few months later, the second Ebola virus 
emerged from Yambuku, Zaire, Ebola-Zaire (EBOZ). EBOZ, with the highest mortality rate of any of the Ebola 
viruses (88%), infected 318 people. The third strain of Ebola, Ebola Reston (EBOR), was first identified in 1989 
when infected monkeys were imported into Reston, Virginia, from Mindanao in the Philippines. Fortunately, the 
few people who were infected with EBOR (seroconverted) never developed Ebola hemorrhagic fever (EHF). In 
2008, however, Reston ebolavirus was discovered in pigs during an unusually severe outbreak of porcine 
reproductive and respiratory syndrome (PRRS) in the Philippines. Recently, this virus was also found in pigs with 
PRRS in China (Spickler and Anna, 2014). The last known strain of Ebola, Ebola Cote d'Ivoire (EBO-CI) was 
discovered in 1994 when a female ethologist performing a necropsy on a dead chimpanzee from the Tai Forest, 
Cote d'Ivoire, accidentally infected herself during the necropsy (Waterman, 1999).  
April 3, 2014 -WHO is supporting the national authorities in the response to an outbreak of Ebola virus 
disease (EVD; formerly known as Ebola haemorrhagic fever). The outbreak is now confirmed to be caused by a 
strain of ebolavirus with very close homology (98%) to the Zaire ebolavirus. This is the first time the disease has 
been detected in West Africa.  Cases were first reported from forested areas in South-eastern Guinea. The outbreak 
has rapidly evolved and several districts and Conakry have reported cases and deaths caused by EVD. A small 
number of suspected cases and deaths have also been reported from neighboring countries with all of them having 
crossed from Guinea. Confirmed cases have been reported from Guinea and Liberia (WHO, 2014). 
This year, Ebola virus returned to the center stage as the Western African countries of Guinea, Liberia, 
and Sierra Leone are facing an unprecedented and uncontrolled outbreak caused by a new Zaire Ebola virus strain. 
The number of cases in this outbreak has surpassed that for all previously reported Ebola virus outbreaks combined 
(Halfmann et al., 2014). 
 
2.2. Etiology 
The causative agent is classified in the genus Ebolavirus of the Filoviridae family of order Mononegavirales.  
Filoviruses are filamentous enveloped viruses containing a non-segmented, negative-strand genomic RNA of 
approximately 19 kilobases. The virus family Filoviridae includes 3 genera: Cuevavirus, Marburgvirus, and 
Ebolavirus.  The names of these viruses have undergone several taxonomic changes since they were first 
discovered, including new changes officially accepted in 2013. Currently, the genus Ebolavirus contains five 
recognized viral species: Zaire ebolavirus, Sudan ebolavirus, Taï Forest ebolavirus (formerly Cote d’Ivoire 
ebolavirus), Reston ebolavirus and Bundibugyo ebolavirus. The common name for the single virus in each of these 
species is Ebola virus (formerly Zaire ebolavirus), Sudan virus (formerly Sudan ebolavirus), Tai Forest virus 
(formerly Cote d’Ivoire ebolavirus), Reston virus (formerly Reston ebolavirus) and Bundibugyo virus (formerly 
Bundibugyoebolavirus). The Bundibugyo ebolavirus, Zaire ebolavirus, and Sudan ebolavirus have been associated 
with large outbreaks in Africa. The virus causing the 2014 West African outbreak belongs to the Zaire species 
(Sarah, 2014).  
Ebola virus is nonsegmented, negative-sense, single-stranded RNA virus that resemble rhabdoviruses and 
paramyxoviruses in its genome organization and replication mechanisms (Mike, 2014). The following figure 
shows Electron microscopically appearance for Ebola virus particle and its characteristic filamentous shape. 
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Figure-1: Ebola virus particles and its characteristic filamentous shape. 
Source: (Feldmann, 2014) 
 
2.3. Epidemiology 
Ebola virus, was first recognized when two outbreaks occurred in Zaire and in Sudan in 1976.  An epidemic caused 
by the Zaire species caused several hundred cases in 1995 in Kikwit, Democratic Republic of the Congo, and the 
Sudan virus infected more than 400 people in Gulu, Uganda in 2000 (Mike and Daniel, 2015).  
Currently, West Africa is facing the largest outbreak of Ebola virus disease (EVD) in history. The virus 
causing this outbreak, the Zaire Ebolavirus (EBOV), belongs to the genus Ebolavirus which together with the 
genus Marburgvirus forms the family of the Filoviridae. EBOV is one of the most virulent pathogens among the 
viral haemorrhagic fevers, and case fatality rates up to 90% have been reported. Mortality is the result of multi-
organ failure and severe bleeding complications (Goeijenbier et al., 2014). 
In addition to causing human infections, Ebola virus has also spread to wild nonhuman primates, 
apparently as a result of their contact with an unidentified reservoir host, possibly bats. This has contributed to a 
marked reduction in chimpanzee and gorilla populations in Central Africa, and has also triggered some human 
epidemics due to handling of and/or consumption of sick or dead animals by local villagers as a source of food 
(Leroy et al., 2004).   
Although all previous Ebola outbreaks occurred in Central Africa, an epidemic began in the West African 
nation of Guinea in late 2013 and was confirmed by the World Health Organization (WHO) in March 2014 (Baize 
et al., 2014;WHO, 2014). The outbreak subsequently spread to Liberia, Sierra Leone, Nigeria, Senegal, and Mali 
(Gore et al., 2014). The 2014-2015 Ebola epidemic, caused by the Zaire species of virus, is not only the first to 
occur in West Africa, but is far larger than all previous outbreaks combined (Mike and Daniel, 2015). 
2.3.1. Geographical distribution 
The disease typically occurs in outbreaks in tropical regions of Sub-Saharan Africa. Confirmed cases of EVD have 
been reported in Africa such as Liberia, Sierra Leone, Guinea, Ghana, Nigeria, the Democratic Republic of the 
Congo, Gabon, Sudan, the Ivory Coast, and Uganda (Nishiura and Chowell, 2014).  
Geographic distribution of Ebola viruses may overlap with the range of the fruit bats. However, there is 
no evidence that it is present in Australian bats or other animals in Australia. There have been no cases in Australia 
(CDC, 2014b). Reston ebola virus occurs in the Philippines. This or other filoviruses might also exist in other 
locations (Spickler and Anna, 2014).  
Table1: Species of Genus Ebola virus with their distribution and fatality rate. 
Species                                   Virus          Region            Fatality Rate 
Zaire ebolavirus                      EBOV          Africa            60-90%  
Sudan ebolavirus                   SUDV           Africa            40-60% 
Bundibugyoebolavirus           BDBV          Africa             25%, based on one outbreak 
Tai forest ebolavirus             TAFV           Africa             Unknown, only one known  infection in Ivory Coast 
Reston ebolavirus                  RESTV        Asia                 Not known to cause lethal infections in humans.   
Source: (Semalulu et al., 2014) 
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Figure-2: Recent geographical distribution of EVD in four African countries. Source: (Anthony and Fauci, 2014) 
2.3.2. Host range / susceptible species  
a)  Natural host of Ebola virus 
Fruit bats of the Pteropodidae family are considered to be the natural host of the Ebola virus. Although non-human 
primates have been a source of infection for humans, they are not thought to be the reservoir but rather an accidental 
host like human beings. Since 1994, Ebola outbreaks from the EBOV and TAFV species have been observed in 
chimpanzees and gorillas (Olival et al., 2013). Therefore, monkeys are not considered as natural hosts because of 
their high sensitivity to the virus and their high mortality rate when infected (Radford and Scott, 2014). 
Dogs and pigs are so far the only domestic animals identified as species that can be infected with EBOV. 
While infections in dogs appear to be asymptomatic, pigs experimentally infected with EBOV can develop clinical 
disease, depending on the virus species and possibly the age of the infected animals (Weingartl et al., 2013). Non-
human primates are in general highly susceptible to filovirus infections. Large outbreaks of lethal Ebola virus 
infections have been reported in wild populations of gorillas (Gorilla gorilla) and chimpanzees (Pan troglodytes) 
(Elias et al., 2014). Other animals such as duikers (a species of forest antelope, Cephalophusdorsalis), bush pigs 
(red river hog, Potamochoerusporcus) are also affected (Spickler and Anna, 2014). 
2.3.3. Risk factors 
How filoviruses are transmitted between bats, or transmitted from bats to other animals or human, is still uncertain. 
Although these viruses can be found in bat tissues and blood, they typically seem to be absent from secretions or 
excretions such as oral fluids, urine and feces. There is some evidence that transmission might occur when bats 
give birth. Seasonal changes in the prevalence of Marburg virus RNA were reported in older juvenile Egyptian 
fruit bats, with peaks during the twice-yearly birthing seasons. These peaks seem to coincide with a higher risk of 
human infection. Pregnant fruit bats are also more likely to be seropositive than nonpregnant females (Spickler 
and Anna, 2014). 
Although canine infection by Ebola virus has never been documented, domestic dogs’ behavior and diet 
place them at risk. Several dogs were highly exposed to Ebola virus by eating infected dead animals. Transmission 
among chimpanzees through meat consumption constitutes a significant risk factor, whereas contact between the 
animals, such as touching dead bodies and grooming is not (Loïs et al., 2005).  
2.3.4. Transmission   
Epidemics of Ebola virus disease are generally thought to begin when an individual becomes infected through 
contact with the meat or body fluids of an infected animal. Once the patient becomes ill or dies, the virus then 
spreads to others who come into direct contact with the infected individual’s blood, skin, or other body fluids. 
Studies in laboratory primates have found that animals can be infected with Ebola virus through droplet inoculation 
of virus into the mouth or eyes (Jaax et al., 1996).   
Ebola is not spread through the air, by water, or in general, by food. However, in Africa, Ebola may be 
spread as a result of handling bushmeat (wild animals hunted for food) and contact with infected bats. There is no 
evidence that mosquitoes or other insects can transmit Ebola virus. Only a few species of mammals (e.g., humans, 
bats, monkeys, and apes) have shown the ability to become infected with and spread Ebola virus (CDC, 2015). 
a) Animal to human 
Although it is not entirely clear how Ebola initially spreads from animals to humans, the spread is believed to 
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involve direct contact with an infected wild animal or fruit bat. Besides bats, other wild animals sometimes infected 
with EBOV include several monkey species, chimpanzees, gorillas, baboons and duikers. In Africa, wild animals 
including fruit bats are hunted for food and are referred to as bush meat. In equatorial Africa, human consumption 
of bush meat has been linked to animal-to-human transmission of diseases, including Ebola (Sarah, 2014).  
b) Human to human  
Person-to-person transmission follows and can lead to large numbers of affected people. In some past Ebola 
outbreaks, primates were also affected by Ebola and multiple spillover events occurred when people touched or 
ate infected primates. When an infection occurs in humans, the virus can be spread to others through direct contact 
through broken skin or mucous membranes in, for example, the eyes, nose, or mouth  with  blood or body fluids 
including but not limited to urine, saliva, sweat, feces, vomit, and breast milk of a person who is sick with or has 
died from Ebola, objects like needles and syringes that have been contaminated with body fluids from a person 
who is sick with Ebola or the body of a person who has died from Ebola, infected fruit bats or primates (apes and 
monkeys), and possibly from contact with semen from a man who has recovered from Ebola for example, by 
having oral, vaginal, or anal sex (CDC, 2014b). 
Dead bodies remain infectious; thus, people handling human remains in practices such as traditional burial 
rituals or more modern processes such as embalming are at risk. No spread by mosquitos or other insects has been 
reported (Chan, 2014). 
c) Among non human primates/domestic animals 
The extent of transmission between nonhuman primates during outbreaks in the wild is controversial; however, 
current evidence suggests that these viruses are not spread efficiently, and nonhuman primates are unlikely to act 
as maintenance hosts. Virus spread is likely to depend on the extent of interactions between members of the 
population, as well as the infectivity of body fluids and carcasses. Domestic animals become infected when they 
eat fruit partially eaten by bats carrying the virus. Fruit production, animal behavior and other factors may trigger 
outbreaks among animal populations. Evidence indicates that both domestic dogs and pigs can also be infected 
with EBOV (Spickler and Anna, 2014). 
 
3. Infections in Animal 
Although its clinical course is well known, the specific mechanisms underlying the pathogenicity of Ebola virus 
have not been clearly delineated. This is due, in part, to the difficulty in obtaining samples and studying the disease 
in the relatively remote areas in which the outbreaks occur. In addition, a high degree of biohazard containment is 
required for laboratory studies and clinical analysis (Sullivan et al., 2003). 
  
3.1. Incubation Period 
Experimental inoculation of nonhuman primates with filoviruses often results in clinical signs after 3-5 days, 
although the incubation period was reported to be as long as 16 days in some animals. Pigs developed a fever 4 
days after inoculation with Zaire ebolavirus (Murphy, 2014). 
 
3.2. Pathogenesis 
Experimental evidences show that the pathologic alterations found in Ebola virus infection of man and 
experimental animals are similar. Ebola viruses have all been associated with hemorrhagic fever in humans and/or 
non-human primates with differences in pathogenicity (Chepurnov et al., 2001).   
The virus first attacks and invades dendrites cells that alert the body to infection. By doing this, the virus 
can evade the immune system and begin replicating itself. Infected cells rupture, releasing more virus particles 
into the body as well as a flood of cytokines molecules that cause fever and inflammation. This “cytokine storm” 
damages blood vessels and causes internal bleeding. Certain white blood cells called neutrophils, which would 
normally fight an infection, can act as carriers and spread the Ebola virus throughout the body. After the virus has 
spread through the body, death is most often attributed to severe blood loss and massive organ failure (WHO, 
2014).  
 
3.3. Clinical Signs 
Symptoms may appear anywhere from 2 to 21 days after exposure to Ebola, but the average is 8 to 10 days (CDC, 
2014a). African species of Ebolaviruses are usually more pathogenic than Reston ebolavirus: the clinical signs are 
more severe, hemorrhages are more common and the mortality rate is higher (Spickler and Anna, 2014).  
In humans, initial symptoms are nonspecific - may include fever, chills, myalgias, and malaise. Patients can 
progress to develop gastrointestinal symptoms: severe watery diarrhea, nausea, vomiting and abdominal pain. 
Bleeding not universally present but can manifest later as petechiae, ecchymosis/bruising, or oozing. Frank 
hemorrhage is less common. Some develop diffuse erythematous maculopapular rash that can desquamate (CDC, 
2014c). 
Nonhuman primates are severely affected by filoviruses. Wild chimpanzees and gorillas are often found 
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dead. Clinical signs observed in dying wild animals (of various species) during Ebolavirus outbreaks have included 
vomiting, diarrhea, hair loss and emaciation, as well as bleeding from the nostrils (Gary, 2005).  
Clinical signs in pig include high fever 41oC, labored breathing, coughing, nasal discharge, loss of 
appetite, diarrhea and skin hemorrhage/reddish discoloration. Some found in recumbent position. Sows previously 
affected by high fever and abortions. Piglets inoculated with Zaire ebolavirus developed a fever and respiratory 
signs, which progressed to dyspnea, anorexia and lethargy. Guinea pigs infected with unpassaged filoviruses from 
primates may have a fever and weight loss, but recover. In this species, severe illness is only seen in animals 
infected with serially passaged virus adapted to guinea pigs. No clinical signs have been reported in infected wild 
bats and dogs (Goldsmith and Zaki, 2010). 
 
3.4. Post Mortem Lesions 
Petechiae, ecchymoses and frank hemorrhages may be present at necropsy. Hemorrhages can occur in any organ, 
but they are particularly common in the gastrointestinal tract, kidneys, and pleural, pericardial and peritoneal 
spaces. The liver and spleen may be swollen and friable, and the liver may be severely reticulated and discolored. 
Other potential lesions include interstitial pneumonia, nephritis, as well as necrosis of the liver, lymphoid tissue, 
adrenal cortex or pulmonary epithelium (Spickler and Anna, 2014). The right atrium was hemorrhagic in some 
animals, although the cause of this lesion was uncertain. Mild lung and lymph node lesions were reported in some 
asymptomatic piglets infected with Reston ebolavirus. The gross lesions in young pigs experimentally infected 
with Zaire ebolavirus were pulmonary consolidation and enlargement of the lung-associated lymph nodes, which 
were sometimes mildly hemorrhagic (Peter et al., 1994). 
 
3.5. Diagnosis and Treatment 
The diagnosis of EVD is confirmed by isolating the virus, detecting its RNA or proteins, or detecting antibodies 
against the virus in a blood. Isolating the virus by cell culture, detecting the viral RNA by polymerase chain 
reaction (PCR) and detecting proteins by enzyme-linked immunosorbent assay (ELISA) are methods best used in 
the early stages of the disease. Detecting antibodies against the virus is most reliable in the later stages of the 
disease and in those who recover (Grolla et al., 2005). 
During an outbreak, isolation of the virus via cell culture methods is often not feasible. In field or mobile 
hospitals, the most common and sensitive diagnostic methods are real-time PCR and ELISA. Filovirions, such as 
EBOV, may be identified by their unique filamentous shapes in cell cultures examined with electron microscopy, 
but this method cannot distinguish the various Filoviruses. In primates, Filoviruses occur in high concentrations 
in the liver, spleen, lungs, lymph nodes and skin. Liver, spleen, muscle and skin have been taken from wild animal 
carcasses in good condition for surveillance by RT-PCR. In bats, filoviruses have been found in tissues such as 
the liver and spleen, and sometimes in the blood. Electron microscopy can identify virus particles, which have a 
distinctive, filamentous pleomorphic, appearance, in tissues (Spickler and Anna, 2014). 
The most important differential for EVD in humans and non-human primates is Marburg virus which is 
a related virus that causes hemorrhagic fevers (Grolla et al., 2005). African swine fever, classical swine fever, 
hemorrhagic gastroenteritis toxic shock syndrome and gram-negative bacteria septicemia in pigs are also 
associated with hemorrhage (SFDPH, 2008). In human diseases like influenza, measles, rubella, dengue 
hemorrhagic fever, hemorrhagic varicella, hemorrhagic smallpox, shigellosis, Chlamydia infection, borreliosis, 
leptospirosis, rickettsiosis, hantavirus pulmonary syndrome and malaria are some of diseases associated with 
hemorrhagic fever (WHO, 2014). 
Most Filovirus infections are serious and often fatal in both humans and nonhuman primates, infected 
animals are usually euthanized (Oestereich et al., 2014).  
There’s no cure for Ebola, though researchers are working on it. Currently, the treatment of EVD includes  
an experimental serum that destroys infected cells, the administration of supportive care and treatment strategies 
such as fluids and electrolytes,oxygen, blood pressure medication, blood transfusions and treatment for other 
infections (Brunilda, 2014). 
The WHO declared that, considering the magnitude and severity of the current outbreak, it is ethical to 
use experimental drugs for treatment and prevention of EVD. Zmapp is a cocktail of monoclonal antibodies and 
is being used to treat some victims of the current EBOV outbreak. Its role in treatment of EVD still needs to be 
established since efficacy data in humans have not been published yet. The strongest evidence that Zmapp is indeed 
effective in EVD comes from experiments in non-human primates in which Zmapp was able to revert advanced 
EVD when administered up to five days post infection (Quix et al., 2014). Recently, the drug gained approval in 
Japan for use in humans infected with novel and re-emerging influenza viruses. Besides activity against influenza 
virus infection, this drug also has documented activity against a wide variety of RNA viruses including 
Ebolaviruses (Smither et al., 2014).   
Hemopurifier is another alternative way of treatment for Ebola virus patient.The Hemopurifier is a single-
use disposable cartridge designed for use with dialysis machines and other blood circulatory pumps. It functions 
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to selectively remove harmful substances from the blood, giving a potential method of addressing diseases. During 
October 2014 the Hemopurifier was used as an adjunct in the treatment of a patient who was suffering from Ebola, 
who subsequently recovered (FDA, 2014). 
 
3.6. Control and Prevention 
3.6.1. Disease reporting  
Animals that may be infected with Ebola viruses must be reported immediately, to protect humans who may be 
exposed and aid in controlling the outbreak (Spickler and Anna, 2014). 
3.6.2. Good food preparation practices 
Ebola viruses, as well as other microbes, are not transmitted through consumption of well-cooked food. Ebola 
viruses are inactivated by normal temperatures used for cooking (so that food reaches 60 °C in all parts “piping” 
hot); it is safe to eat properly prepared and cooked meat. Proper food preparation includes hand washing before 
and after handling food, hand washing in between handling raw food and cooked or ready-to eat food, keeping 
raw meat separate from cooked or ready-to-eat foods, keeping utensils and surfaces used to prepare raw meats 
separate from those used for other foods (e.g. chopping boards, knives and plates); and washing and disinfecting 
all surfaces and utensils that have been in contact with raw meat (WHO, 2014). 
3.6.3. Animal testing for Ebola virus 
Currently, routine testing for Ebola is not available for animals. Ebola virus testing of animal samples will be 
limited to cases where testing is specifically warranted based on the type of exposure assessment in consultation 
with Centers for Disease Control and Prevention (CDC) on a case-by-case basis. No samples will be tested without 
pre-authorization from CDC. In the event that an animal has a confirmed positive RT-PCR for Ebola virus RNA, 
the animal should be euthanized and the body incinerated (AVMA, 2014). 
3.6.4. Routine cleaning and disinfection 
Since, no animal vaccine against the virus is available. Routine cleaning and disinfection of pig or monkey farms 
(with sodium hypochlorite or other detergents) should be effective in inactivating the virus (WHO, 2014). 
3.6.5. Quarantine, biosecurity measures and culling of infected animals 
Quarantine of nonhuman primates during importation protects humans and healthy nonhuman primates from 
exposure to filoviruses. During outbreaks, suspects and exposed animals should be isolated, and euthanized after 
confirmation of the disease. Strict infection control procedures are necessary to prevent virus transmission on 
fomites. If an outbreak is suspected, the premises should be quarantined immediately. Measures to prevent 
infection of swine with Reston ebolavirus in endemic areas have not yet been established, but normal biosecurity 
measures should be helpful. Pigs should not be allowed to contact bats or nonhuman primates. Culling of infected 
animals, with close supervision of burial or incineration of carcasses, may be necessary to reduce the risk of 
animal-to-human transmission. Restricting or banning the movement of animals from infected farms to other areas 
can reduce the spread of the disease (WHO, 2014). 
 
4. States of Evd in Ethiopia and the Major Control Measure Taken   
Following the outbreak in Guinea, Sierra Leone, Liberia and Nigeria, Ebola virus disease (EVD) was declared as 
a public health emergency of international concern by the WHO Director General on 8 August 2014. The Federal 
Ministry of Health (FMoH) has taken the necessary measures to prevent the spread of Ebola virus disease to 
Ethiopia. The Government high-level task force is chaired by the Deputy Prime Minister on behalf of the Prime 
Minister, and the high-level task force involving different partners is chaired by the Minister of Health. FMoH 
held an orientation workshop on 6 August on Ebola virus disease outbreak preparedness and response to health 
workers on surveillance (case detection and reporting), risk factors, clinical signs and symptoms and precautions 
to be taken for infection prevention. More than 200 health workers from government and private hospitals, NGOs, 
health centers, health bureaus and sub-cities in Addis Ababa and Ethiopian Airlines Clinic attended the orientation. 
Also present were representatives from the WHO, the US Center for Disease Control and Prevention (CDC) and 
Japan Embassy (WHO, 2014). 
There is no report of Ebola virus disease in Ethiopia so far. Screening for cases and high risks has been 
established at Bole International Airport for the travelers from West Africa particularly affected by the epidemic. 
The screening is expanding to the major land ports these days. Screening all others who have travel history to 
affected countries at 8 major land crossing: Moyale, Togowachale, Dewale, Galafi, Humera, Metema, Kumruk 
and Gambella. Training of rapid response team, focal persons and clinicians from regional hospitals, allocation of 
transportation service, personal protective equipments, infection prevention materials, isolation center, laboratory 
supplies and free calling service (8335) for rapid information and report of any suspected cases are some major 
preparation take by Ministry of Health in Ethiopia (Daddi, 2014). 
As January 15, 2015, an Ethiopian patient suspected to have been suffering from Ebola died in the capital, 
Addis Ababa, on Wednesday. The patient, who recently returned from Sierra Leone, one of the worst-hit West 
African countries, was quarantined following his arrival at Addis Ababa Airport two weeks ago after showing 
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Ebola-like symptoms. However, Ethiopian health minister Dr Keseteberhan Admassu on Thursday has dismissed 
speculation the patient had died of Ebola, saying tests had confirmed he was not infected with the virus (Tesfalem, 
2015). 
 
5. Public Health and Economic Importances 
Ebola virus disease is an important zoonotic disease (except Ebola- Reston) and currently its outbreaks constitute 
a major public health issue in western Africa. Just how Ebola actually gets from animals or the environment and 
into humans is unclear. The virus probably "resides" in bats. From there it may occasionally infect humans that 
directly handle or eat bats. Humans may find the dead "intermediate" animal and then eat its meat ("bushmeat"). 
Either way, in each outbreak, the first human to be infected is called the "index case". This person can then infect 
others, especially in areas where hygiene, sanitation and infection control levels are low. Researchers believe that 
the first patient becomes infected through contact with an infected animal. When an infection does occur in humans, 
the virus can be spread in several ways to others (Goldsmith and Zaki, 2010). 
Reflecting alarmism owing to the disease, as well as EVD-related mortality and morbidity, economic 
activity has shrunk. This contraction reflects multiple cross-currents, falling sales in markets and stores, lower 
activity for restaurants, hotels, public transport, construction and educational institutions (also caused by 
government measures such as a state of emergency and restrictions on people’s movements) and slowing activity 
among foreign companies as many expatriates leave, with a knock on felt in lower demand for some services 
(United Nations Economic Commission for Africa, 2014). Households have less access to basic goods on the 
market because of reduced incomes resulting in a change in eating habits; supply of goods is constrained due to 
border and market closures, as well as transportation problems; and challenges in the agricultural sector may affect 
farmers’ ability to have a normal harvest in the upcoming planting seasons. Some of these issues may have 
immediate remedies, while others will require medium to long-term interventions (Monrovia, 2014). 
With a large expansion of the outbreak, and Ebola spreading to other countries in the region, children 
would lose their providers, households would suffer losses to their income, businesses would lose workers to death, 
illness, and fear, and industries like mining and agriculture would slow down significantly. Ebola virus outbreaks 
also provide dreadful publicity for tourism and investment (Leroy et al., 2004).  
 
6. Conclusion and Recommendations  
In conclusion, very little is known about how domestic animals respond to Ebola virus and there is no evidence 
that domestic animals play an active epidemiological role in the transmission of the disease to humans. The only 
domestic animals that have been found to be susceptible to Ebola viruses are dogs and pigs. Dogs showed little to 
no discernible symptoms of the virus; while pigs showed mild to severe symptoms. The asymptomatic infection 
of dogs by Ebola virus in the wild has potential implications for preventing and controlling human outbreaks. Wild 
animals such as fruit bats, non human primates, duikers and bush pigs are affected by Ebola virus disease with 
fruit bat and non human primates are the potential source for human infection. However, non human primates are 
not considered as natural hosts because of their high sensitivity to the virus and their high mortality rate when 
infected. Therefore, fruit bats are considered to be the only natural host of the Ebola virus.  How filoviruses are 
transmitted between bats, or transmitted from bats to other animals or human, is still uncertain. There is some 
evidence that transmission might occur when bats give birth. Domestic animals become infected when they eat 
fruit partially eaten by bats carrying the virus. People can become sick with Ebola after coming in contact with 
infected bats and handling or consuming of bushmeat.  
Based on the above conclusions, the following recommendations are forwarded:- 
 It is important to step up wildlife monitoring activities and develop operational cooperation between 
animal health services and public-health authorities to ensure early warning of possible human Ebola 
outbreaks.  
 As soon as there are rumours of animal die-off, national park services (or veterinary services) should take 
specimens from dead animal carcasses for diagnostic purposes, using protective equipment. The 
specimens must be sent to a reference laboratory for analysis. As soon as animal cases are confirmed, 
animal health services must alert the public health authorities so they can put in place programmes to 
prevent a human outbreak. 
 Here in Ethiopia, studies should be conducted on the presence and distribution of fruit bats together with 
the seroprevalance of the disease within it since it is very serious and can result in human outbreaks.  
 Further studies should be needed to investigate the possible natural host, susceptible animal species and 
way of transmission of the disease and so as to establish the possible control measures for the disease. 
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